MRSHMarsh McLennan
$197.52+7.0% 1Y
$197.52
$157.3252 weeks$199.31
The financials
Marsh McLennan by the numbers
Marsh McLennan (MRSH) reported revenue of $6.86B in Q3 2026 (quarter ended Sep 30, 2026), up 8.1% from the same quarter a year earlier. That came with net income of $808M (12% of revenue). For the full year FY2025, revenue was $27.0B (+10% year on year) and net income $4.16B. Its largest product in Q2 2026 (quarter ended Jun 30, 2026) was Wealth at $740M, 46% of the disclosed total, ahead of Health at 38%. The next results filing is expected around Jan 28, 2027, the same week as a year ago.
| Income statement | Q3 2026 | Q3 2025 | Change |
|---|---|---|---|
| Revenue | $6.86B | $6.35B | +8.1% |
| Operating income | $1.22B | $1.17B | +3.8% |
| Net income | $808M | $747M | +8.2% |
| Diluted EPS | $1.69 | $1.51 | +12% |
| Product | Revenue | Share |
|---|---|---|
| Wealth | $740M | 46% |
| Health | $611M | 38% |
| Career | $247M | 15% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q2 2026Total $1.60B (-3.8%)
Career grew +13% year on yearHealth +2.9% year on year
Segment Latestquarter on quarteryear on year
- Wealth$740.0M$740.0Mquarter on quarter -1.6%year on year +8.0%-1.6%+8.0%
- Health$611.0M$611.0Mquarter on quarter -7.6%year on year +2.9%-7.6%+2.9%
- Career$247.0M$247.0Mquarter on quarter -0.40%year on year +13%-0.40%+13%
On our screens:Stocks that buy back more than they dilute
Insurance Brokers
The closest names by size in the same industry